Expert Interview
Discussing the recent FDA flux with the mRNA-1010 application in influenza and possibly contagion to other products including CD388 from Merck
Ticker(s): MRNA, MRKInstitution: Private Practice
- Board certified in Internal Medicine and Infectious Disease
- Familiar with CMV infection and health complications
- Private practice serves patients across five nearby acute care hospitals
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
